이 에피소드에 관해
4basebio PLC (AIM:4BB, FRA:8L7, ETR:88Q) CEO Amy Walker joined Proactive's Stephen Gunnion to discuss the company's synthetic DNA platform, growing commercial momentum and key milestones for investors.
Walker explained how 4basebio's enzyme-based technology provides a cleaner, faster and more cost-effective alternative to conventional plasmid DNA manufacturing, supporting applications in cell and gene therapy, vaccines and gene editing. She also highlighted the launch of the company's single-stranded DNA product, which offers lower toxicity and the ability to produce longer DNA molecules for advanced gene editing.
The interview also covers a recent Phase 2 clinical supply agreement, the appointment of mRNA expert Jeff Coller to the Strategic Advisory Board, expansion of the company's Cambridge manufacturing facility and the commercial milestones investors should watch for over the coming months.
For more interviews and market insights, visit Proactive's YouTube channel. Don't forget to like this video, subscribe to the channel and enable notifications so you never miss future content.
#4basebio #SyntheticDNA #DNAManufacturing #GeneEditing #CRISPR #CellTherapy #GeneTherapy #Biotech #Biotechnology #LifeSciences #mRNA #Vaccines #PersonalizedMedicine #CancerVaccines #HealthcareInnovation #ClinicalTrials #CambridgeBiotech #Investing #SmallCapStocks #ProactiveInvestors
Walker explained how 4basebio's enzyme-based technology provides a cleaner, faster and more cost-effective alternative to conventional plasmid DNA manufacturing, supporting applications in cell and gene therapy, vaccines and gene editing. She also highlighted the launch of the company's single-stranded DNA product, which offers lower toxicity and the ability to produce longer DNA molecules for advanced gene editing.
The interview also covers a recent Phase 2 clinical supply agreement, the appointment of mRNA expert Jeff Coller to the Strategic Advisory Board, expansion of the company's Cambridge manufacturing facility and the commercial milestones investors should watch for over the coming months.
For more interviews and market insights, visit Proactive's YouTube channel. Don't forget to like this video, subscribe to the channel and enable notifications so you never miss future content.
#4basebio #SyntheticDNA #DNAManufacturing #GeneEditing #CRISPR #CellTherapy #GeneTherapy #Biotech #Biotechnology #LifeSciences #mRNA #Vaccines #PersonalizedMedicine #CancerVaccines #HealthcareInnovation #ClinicalTrials #CambridgeBiotech #Investing #SmallCapStocks #ProactiveInvestors
영어
미국
전사 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
이 팟캐스트의 다른 에피소드
Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S) CEO Matthew Wood spoke with Proactive's Stephen Gunnion about the company's new co-funded proof-of-concept agreement with a top-five global automotive original equipment manufacturer (OEM) to evaluate its nano-encapsulated sulfur (NES) cathode active materi…
First Graphene Limited commercial manager Neil Armstrong talked with Proactive about the company's first production order from US footwear company Flux Footwear, marking an expansion of its PureGRAPH® graphene materials into the global sports and leisure footwear market.
Armstrong explained that F…
Kingfisher Mining Ltd (ASX:KFM) managing director Chris Bittar talked with Proactive about the company's $2.25 million capital raising and plans to accelerate copper-gold exploration at its Copper Blow Project in Broken Hill, New South Wales.
The placement, priced at 7.5 cents per share, represent…
Horizon Gold Ltd (ASX: HRN) managing director Scott Williamson talked with Proactive about the company's latest drilling results at its 100%-owned Gum Creek Gold Project in Western Australia, highlighting high-grade gold mineralisation at Snook and further resource growth opportunities across its e…
Cyprium Metals executive chairman Matt Fifield talked with Proactive about key commissioning milestones at the Nifty Copper Complex in Western Australia, as the company advances heap leach operations and prepares for first copper cathode production.
Fifield explained that commissioning activities …
면책 조항: 이 페이지에 포함된 팟캐스트와 작품은 Proactive에서 가져온 것입니다. 이 팟캐스트는 소유자의 재산이며 Listen Notes, Inc.와 제휴하거나 보증하지 않습니다.
